News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
824,177 Results
Type
Article (62070)
Company Profile (749)
Press Release (761330)
Multimedia
Podcasts (196)
Webinars (31)
Section
Business (226317)
Career Advice (3532)
Deals (39054)
Drug Delivery (165)
Drug Development (88996)
Employer Resources (194)
FDA (18082)
Job Trends (16941)
News (384643)
Policy (37520)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (2995)
Academic (1)
Accelerated approval (48)
Adcomms (39)
Allergies (184)
Alliances (55167)
ALS (222)
Alzheimer's disease (1917)
Antibody-drug conjugate (ADC) (488)
Approvals (18368)
Artificial intelligence (742)
Autoimmune disease (301)
Automation (58)
Bankruptcy (404)
Best Places to Work (12552)
BIOSECURE Act (23)
Biosimilars (235)
Biotechnology (462)
Bladder cancer (196)
Brain cancer (80)
Breast cancer (789)
Cancer (6099)
Cardiovascular disease (516)
Career advice (3023)
Career pathing (48)
CAR-T (354)
CDC (72)
Celiac Disease (3)
Cell therapy (978)
Cervical cancer (47)
Clinical research (76448)
Collaboration (2231)
Company closure (8)
Compensation (1416)
Complete response letters (100)
COVID-19 (3012)
CRISPR (119)
C-suite (1181)
Cystic fibrosis (162)
Data (7915)
Decentralized trials (3)
Denatured (64)
Depression (184)
Dermatology (85)
Diabetes (623)
Diagnostics (7456)
Digital health (58)
Diversity (12)
Diversity, equity & inclusion (48)
Drug discovery (361)
Drug pricing (242)
Drug shortages (38)
Duchenne muscular dystrophy (302)
Earnings (99083)
Editorial (77)
Employer branding (24)
Employer resources (168)
Events (134781)
Executive appointments (1154)
FDA (21901)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (35)
Funding (1826)
Gene editing (259)
Generative AI (69)
Gene therapy (804)
GLP-1 (1237)
Government (5414)
Grass and pollen (8)
Guidances (411)
Healthcare (20823)
HIV (87)
Huntington's disease (61)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (101)
Immunology and inflammation (343)
Immuno-oncology (100)
Indications (181)
Infectious disease (3381)
Inflammatory bowel disease (239)
Inflation Reduction Act (17)
Influenza (144)
Intellectual property (299)
Interviews (684)
IPO (17864)
IRA (61)
Job creations (4762)
Job search strategy (2438)
JPM (72)
Kidney cancer (21)
Labor market (104)
Layoffs (670)
Leadership (49)
Legal (9375)
Liver cancer (107)
Longevity (34)
Lung cancer (800)
Lymphoma (435)
Machine learning (62)
Management (64)
Manufacturing (1106)
MASH (202)
Medical device (15112)
Medtech (15228)
Mergers & acquisitions (22436)
Metabolic disorders (1662)
mRNA (240)
Multiple sclerosis (196)
NASH (24)
Neurodegenerative disease (462)
Neuropsychiatric disorders (123)
Neuroscience (3543)
Neurotech (1)
NextGen: Class of 2026 (7551)
Non-profit (5040)
Now hiring (78)
Obesity (810)
Opinion (365)
Ovarian cancer (221)
Pain (272)
Pancreatic cancer (309)
Parkinson's disease (380)
Partnered (37)
Patents (616)
Patient recruitment (694)
Peanut (67)
People (66027)
Pharmaceutical (128)
Pharmacy benefit managers (36)
Phase 1 (23815)
Phase 2 (33486)
Phase 3 (25060)
Pipeline (8542)
Policy (381)
Postmarket research (2995)
Preclinical (10293)
Press Release (71)
Prostate cancer (309)
Psychedelics (68)
Radiopharmaceuticals (350)
Rare diseases (1182)
Real estate (7002)
Recruiting (78)
Regulatory (28451)
Reports (64)
Research institute (2717)
Resumes & cover letters (555)
Rett syndrome (37)
RNA editing (26)
RSV (98)
Schizophrenia (191)
Series A (312)
Series B (224)
Service/supplier (27)
Sickle cell disease (120)
Special edition (31)
Spinal muscular atrophy (183)
Sponsored (53)
Startups (4239)
State (2)
Stomach cancer (21)
Supply chain (137)
Tariffs (104)
The Weekly (129)
Vaccines (1251)
Venture capital (121)
Weight loss (553)
Women's health (127)
Worklife (24)
Date
Last 7 days (1004)
Last 30 days (3293)
Last 365 days (32315)
2026 (12382)
2025 (32445)
2024 (37788)
2023 (42491)
2022 (53875)
2021 (58613)
2020 (57444)
2019 (50886)
2018 (38685)
2017 (36225)
2016 (36723)
2015 (42727)
2014 (36954)
2013 (32207)
2012 (34264)
2011 (34533)
2010 (32849)
Location
Africa (1067)
Alabama (100)
Alaska (7)
Arizona (377)
Arkansas (16)
Asia (47885)
Australia (8085)
California (13570)
Canada (3804)
China (1426)
Colorado (585)
Connecticut (599)
Delaware (412)
Europe (108301)
Florida (2015)
Georgia (443)
Hawaii (4)
Idaho (66)
Illinois (1146)
India (96)
Indiana (631)
Iowa (25)
Japan (542)
Kansas (138)
Kentucky (55)
Louisiana (45)
Maine (88)
Maryland (1645)
Massachusetts (9912)
Michigan (397)
Minnesota (753)
Mississippi (7)
Missouri (160)
Montana (37)
Nebraska (30)
Nevada (147)
New Hampshire (91)
New Jersey (3628)
New Mexico (34)
New York (3569)
North Carolina (1836)
North Dakota (10)
Northern California (6704)
Ohio (419)
Oklahoma (26)
Oregon (53)
Pennsylvania (2701)
Puerto Rico (30)
Rhode Island (53)
South America (1463)
South Carolina (87)
South Dakota (2)
Southern California (5320)
Tennessee (214)
Texas (2184)
United States (48585)
Utah (408)
Vermont (1)
Virginia (344)
Washington D.C. (88)
Washington State (1122)
West Virginia (4)
Wisconsin (150)
Wyoming (2)
824,177 Results for "the mentholatum company inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
May 5, 2026
·
8 min read
Press Releases
Io Therapeutics, Inc. announces publication of studies on the company’s RXR agonist compound IRX4204 for breast cancer prevention
March 11, 2026
·
3 min read
Press Releases
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company
April 2, 2026
·
4 min read
Press Releases
Renovare Therapeutics, Inc. Announces Company Launch and Collaboration with CU Boulder Awardee of up to $33.5 Million in ARPA-H Funding to Advance Osteoarthritis Regenerative Therapies
April 7, 2026
·
6 min read
Press Releases
Rosalind Franklin University Incubator Company Presents Promising Glioblastoma Therapy Data at Major Brain Cancer Conference
April 7, 2026
·
1 min read
Press Releases
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
Includes Asthma in its strategic plans and Strengthens its Team in 2024-2025
December 18, 2025
·
5 min read
Job Trends
Keeping the Door Open: Many Would Return to Companies That Laid Them Off
Over half of biopharma professionals would work again at the companies that let them go, according to a
BioSpace
LinkedIn poll. Several professionals, as well as recruiting and talent acquisition experts, discuss reasons for—and a key risk of—going back.
March 5, 2026
·
5 min read
·
Angela Gabriel
Press Releases
Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update
April 30, 2026
·
10 min read
Duchenne muscular dystrophy
Entrada crashes as Duchenne therapy comes in ‘below expectations’ in early study
Entrada Therapeutics saw a 2.36% dystrophin increase in patients treated with its oligonucleotide asset—a number that fell short of the company’s prior guidance of a double-digit improvement.
May 7, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation
April 23, 2026
·
6 min read
1 of 82,418
Next
